Telemetry Investments L.L.C. Takes Position in Cigna Corp (CI)

Telemetry Investments L.L.C. bought a new position in Cigna Corp (NYSE:CI) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 2,281 shares of the health services provider’s stock, valued at approximately $433,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Lido Advisors LLC acquired a new stake in Cigna in the fourth quarter worth $274,000. AIMZ Investment Advisors LLC raised its holdings in shares of Cigna by 44.0% during the fourth quarter. AIMZ Investment Advisors LLC now owns 11,665 shares of the health services provider’s stock worth $2,215,000 after acquiring an additional 3,565 shares during the period. Claybrook Capital LLC acquired a new stake in shares of Cigna during the fourth quarter worth $34,000. Mosaic Family Wealth LLC acquired a new stake in shares of Cigna during the fourth quarter worth $241,000. Finally, MUFG Securities EMEA plc raised its holdings in shares of Cigna by 821.2% during the fourth quarter. MUFG Securities EMEA plc now owns 60,781 shares of the health services provider’s stock worth $11,544,000 after acquiring an additional 54,183 shares during the period. Institutional investors own 93.44% of the company’s stock.

In related news, Director John Partridge sold 1,000 shares of the firm’s stock in a transaction on Thursday, February 7th. The shares were sold at an average price of $184.43, for a total value of $184,430.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Brian C. Evanko acquired 2,000 shares of the firm’s stock in a transaction dated Monday, March 11th. The stock was purchased at an average cost of $163.40 per share, with a total value of $326,800.00. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 10,420 shares of company stock valued at $1,886,122. 1.10% of the stock is owned by insiders.

CI has been the topic of a number of research analyst reports. Morgan Stanley dropped their price objective on shares of Cigna from $304.00 to $299.00 and set an “overweight” rating on the stock in a report on Tuesday, February 5th. Wells Fargo & Co dropped their price objective on shares of Cigna from $221.00 to $200.00 and set a “market perform” rating on the stock in a report on Thursday, January 3rd. Credit Suisse Group restated a “buy” rating and set a $250.00 price objective on shares of Cigna in a report on Monday, January 7th. Goldman Sachs Group restated a “buy” rating on shares of Cigna in a report on Saturday, February 2nd. Finally, ValuEngine lowered shares of Cigna from a “hold” rating to a “sell” rating in a report on Friday, December 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $231.28.

Cigna stock opened at $166.45 on Friday. The firm has a market capitalization of $63.26 billion, a P/E ratio of 11.71, a price-to-earnings-growth ratio of 0.81 and a beta of 0.73. Cigna Corp has a 1-year low of $162.42 and a 1-year high of $226.60. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 0.96.

Cigna (NYSE:CI) last released its earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share for the quarter, missing analysts’ consensus estimates of $2.53 by ($0.07). The business had revenue of $13.75 billion during the quarter, compared to the consensus estimate of $11.38 billion. Cigna had a net margin of 5.42% and a return on equity of 16.64%. The firm’s revenue for the quarter was up 29.3% on a year-over-year basis. During the same period last year, the business posted $1.94 EPS. On average, research analysts anticipate that Cigna Corp will post 16.41 earnings per share for the current year.

The firm also recently announced a special dividend, which will be paid on Wednesday, April 10th. Investors of record on Monday, March 11th will be given a $0.04 dividend. The ex-dividend date of this dividend is Friday, March 8th. Cigna’s dividend payout ratio (DPR) is currently 0.28%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Modern Readers and is the sole property of of Modern Readers. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://www.modernreaders.com/news/2019/03/17/telemetry-investments-l-l-c-takes-position-in-cigna-corp-ci.html.

Cigna Company Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: Current Ratio

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.